Screener
TG Therapeutics TGTX Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The source filing: TG Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025955
FAQ
- What is TG Therapeutics's total costs & expenses?
- TG Therapeutics (TGTX) reported total costs & expenses of $218.66M in Q2 2026.
- How has TG Therapeutics's total costs & expenses changed year-over-year?
- TG Therapeutics's total costs & expenses increased by 105.7% year-over-year, from $106.31M to $218.66M.
- What is the long-term trend for TG Therapeutics's total costs & expenses?
- Over 3 years (2021 to 2025), TG Therapeutics's total costs & expenses has grown at a 11.9% compound annual growth rate (CAGR), from $351.46M to $492.96M.
- What does total costs & expenses mean?
- Total costs and expenses represent the sum of all operating costs, including cost of revenue, R&D, and SG&A. It provides a comprehensive view of the total resources consumed by the company to generate its current level of revenue.
Ask your AI about TG Therapeutics's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude